OKYO insider transaction filings
OKYO Pharma Ltd — 19 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-08-07. Screen OKYO transaction legs live →
Insider transaction summary — last 90 days
2026-06-24 to 2026-09-22, from the filings listed below: 14 Form 4 filings. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 7 legs across 7 filings by 6 insiders — 94,363 shares, $136,006 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 7.
- Largest priced transaction: purchase of 25,000 shares @ $1.40 ($35,000) by CERRONE GABRIELE M, filed 2026-08-07.
By insider — same window
Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Insider | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|
| CERRONE GABRIELE M — Director, 10% owner | 4 | 2 legs · 47,500 sh · $67,625 | — | 2 |
| Mantelli Flavio — CHIEF MEDICAL OFFICER | 2 | 1 leg · 20,000 sh · $28,000 | — | 1 |
| Dempsey Robert John — CHIEF EXECUTIVE OFFICER, Director | 2 | 1 leg · 15,000 sh · $23,085 | — | 1 |
| BRANCACCIO JOHN P — Director | 2 | 1 leg · 5,000 sh · $7,385 | — | 1 |
| Patil Rajkumar V. — Chief Scientific Officer | 2 | 1 leg · 3,363 sh · $5,011 | — | 1 |
| JACOB GARY S — CHIEF DEVELOPMENT OFFICER, Director | 2 | 1 leg · 3,500 sh · $4,900 | — | 1 |
Recent Form 4 filings — OKYO Pharma Ltd
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-07 | 4/A | Patil Rajkumar V. — Chief Scientific Officer | Purchase (P): 3,363 @ $1.49 | EDGAR |
| 2026-08-07 | 4/A | Mantelli Flavio — CHIEF MEDICAL OFFICER | Purchase (P): 20,000 @ $1.40 | EDGAR |
| 2026-08-07 | 4/A | CERRONE GABRIELE M — Director, 10% owner | Purchase (P): 25,000 @ $1.40 | EDGAR |
| 2026-08-07 | 4/A | CERRONE GABRIELE M — Director, 10% owner | Purchase (P): 22,500 @ $1.45 | EDGAR |
| 2026-08-07 | 4/A | JACOB GARY S — CHIEF DEVELOPMENT OFFICER, Director | Purchase (P): 3,500 @ $1.40 | EDGAR |
| 2026-08-07 | 4/A | Dempsey Robert John — CHIEF EXECUTIVE OFFICER, Director | Purchase (P): 15,000 @ $1.54 | EDGAR |
| 2026-08-07 | 4/A | BRANCACCIO JOHN P — Director | Purchase (P): 5,000 @ $1.48 | EDGAR |
| 2026-07-29 | 4 | Patil Rajkumar V. — Chief Scientific Officer | Grant/award (A): 3,363 @ $1.49 | EDGAR |
| 2026-07-23 | 4 | Dempsey Robert John — CHIEF EXECUTIVE OFFICER, Director | Grant/award (A): 15,000 @ $1.54 | EDGAR |
| 2026-07-23 | 4 | BRANCACCIO JOHN P — Director | Grant/award (A): 5,000 @ $1.48 | EDGAR |
| 2026-07-23 | 4 | JACOB GARY S — CHIEF DEVELOPMENT OFFICER, Director | Grant/award (A): 3,500 @ $1.40 | EDGAR |
| 2026-07-23 | 4 | CERRONE GABRIELE M — Director, 10% owner | Grant/award (A): 22,500 @ $1.45 | EDGAR |
| 2026-07-22 | 4 | Mantelli Flavio — CHIEF MEDICAL OFFICER | Grant/award (A): 20,000 @ $1.40 | EDGAR |
| 2026-07-21 | 4 | CERRONE GABRIELE M — Director, 10% owner | Grant/award (A): 25,000 @ $1.40 | EDGAR |
| 2026-06-10 | 4 | Shah Keeren Rameshchandra — Chief Financial Officer | Grant/award (A): 40,000 (derivative) @ $1.85 | EDGAR |
| 2026-06-10 | 4 | Denoyer Bernard — Director | Grant/award (A): 3,500 (derivative) @ $1.85 | EDGAR |
| 2026-06-10 | 4 | Simon Willy Jules — Director | Grant/award (A): 6,500 (derivative) @ $1.85 | EDGAR |
| 2026-06-10 | 4 | BRANCACCIO JOHN P — Director | Grant/award (A): 6,500 (derivative) @ $1.85 | EDGAR |
| 2026-06-10 | 4 | CERRONE GABRIELE M — Director, 10% owner | Grant/award (A): 300,000 @ $1.72 | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=OKYO returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →